[HTML][HTML] Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
Y Fan, Y Xu, L Gong, L Fang, H Lu, J Qin, N Han… - Scientific reports, 2017 - nature.com
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.
Y Fan, Y Xu, L Gong, L Fang, H Lu, J Qin, N Han… - Scientific …, 2017 - europepmc.org
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
Y Fan, Y Xu, L Gong, L Fang, H Lu, J Qin… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
Y Fan, Y Xu, L Gong, L Fang, H Lu, J Qin… - Scientific …, 2017 - ui.adsabs.harvard.edu
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
Y Fan, Y Xu, L Gong - Scientific Reports, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> EGFR-TKIs and radiation therapy (RT) are the
principal treatment for patients with brain metastases (BM) and EGFR mutant NSCLC …
principal treatment for patients with brain metastases (BM) and EGFR mutant NSCLC …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.
Y Fan, Y Xu, L Gong, H Lu, J Qin, N Han… - Scientific …, 2017 - search.ebscohost.com
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
[PDF][PDF] Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
G Qiu, Z Huang - cyberleninka.org
Results Patient characteristics. A total of 152 patients with metastatic EGFR-mutant
adenocarcinoma with BM who were diagnosed and received icotinib therapy between …
adenocarcinoma with BM who were diagnosed and received icotinib therapy between …
[HTML][HTML] Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases
Y Fan, Y Xu, L Gong, H Lu, J Qin, N Han, F Xie… - Scientific …, 2017 - ncbi.nlm.nih.gov
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
Effects of icotinib with and without radiation therapy on patients with EGFR mutant non-small cell lung cancer and brain metastases.
Y Fan, Y Xu, L Gong, L Fang, H Lu, J Qin, N Han… - Scientific …, 2017 - europepmc.org
EGFR-TKIs and radiation therapy (RT) are the principal treatment for patients with brain
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …
metastases (BM) and EGFR mutant NSCLC. However, the optimal use of brain RT for …